JPWO2024010045A1 - - Google Patents

Info

Publication number
JPWO2024010045A1
JPWO2024010045A1 JP2024532619A JP2024532619A JPWO2024010045A1 JP WO2024010045 A1 JPWO2024010045 A1 JP WO2024010045A1 JP 2024532619 A JP2024532619 A JP 2024532619A JP 2024532619 A JP2024532619 A JP 2024532619A JP WO2024010045 A1 JPWO2024010045 A1 JP WO2024010045A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532619A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024010045A1 publication Critical patent/JPWO2024010045A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024532619A 2022-07-06 2023-07-05 Pending JPWO2024010045A1 (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022109262 2022-07-06
PCT/JP2023/024981 WO2024010045A1 (ja) 2022-07-06 2023-07-05 疼痛抑制剤

Publications (1)

Publication Number Publication Date
JPWO2024010045A1 true JPWO2024010045A1 (enrdf_load_stackoverflow) 2024-01-11

Family

ID=89453501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532619A Pending JPWO2024010045A1 (enrdf_load_stackoverflow) 2022-07-06 2023-07-05

Country Status (3)

Country Link
JP (1) JPWO2024010045A1 (enrdf_load_stackoverflow)
TW (1) TW202408474A (enrdf_load_stackoverflow)
WO (1) WO2024010045A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025159099A1 (ja) * 2024-01-24 2025-07-31 国立大学法人北海道大学 医薬組成物、眼瞼けいれん処置薬、知覚過敏またはジストニア処置薬、および症状モデルマウス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130165468A1 (en) * 2010-05-13 2013-06-27 Afgin Pharma, Llc Topical peripheral neuro-affective (tpna) therapy
JP2014505113A (ja) * 2011-02-14 2014-02-27 アルカーメス，インコーポレイテッド 末梢作用性μオピオイドアンタゴニスト
US20140088199A1 (en) * 2011-04-05 2014-03-27 Optosolve Llp Ophthalmic treatments
ES2604816B1 (es) * 2015-09-09 2018-01-29 Farmalider, S.A. Composición farmacéutica de tramadol para uso oftálmico

Also Published As

Publication number Publication date
WO2024010045A1 (ja) 2024-01-11
TW202408474A (zh) 2024-03-01

Similar Documents

Publication Publication Date Title
BR102022025291A2 (enrdf_load_stackoverflow)
BR102023014872A2 (enrdf_load_stackoverflow)
JPWO2024010043A1 (enrdf_load_stackoverflow)
BR102023012440A2 (enrdf_load_stackoverflow)
BR102023010976A2 (enrdf_load_stackoverflow)
BR102023009641A2 (enrdf_load_stackoverflow)
BR102023008688A2 (enrdf_load_stackoverflow)
BR102023007252A2 (enrdf_load_stackoverflow)
BR102023005164A2 (enrdf_load_stackoverflow)
BR102023001987A2 (enrdf_load_stackoverflow)
BR102023001877A2 (enrdf_load_stackoverflow)
BR102023000289A2 (enrdf_load_stackoverflow)
BR102022026909A2 (enrdf_load_stackoverflow)
BR102022023461A2 (enrdf_load_stackoverflow)
BR202022009269U2 (enrdf_load_stackoverflow)
BR202022005961U2 (enrdf_load_stackoverflow)
BR202022001779U2 (enrdf_load_stackoverflow)
BR202022000931U2 (enrdf_load_stackoverflow)
BY13145U (enrdf_load_stackoverflow)
BY13155U (enrdf_load_stackoverflow)
BY13139U (enrdf_load_stackoverflow)
BY13140U (enrdf_load_stackoverflow)
BY13142U (enrdf_load_stackoverflow)
BY13143U (enrdf_load_stackoverflow)
BY13163U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250116